分享:
分享到微信朋友圈
X
• 综述 •
多参数磁共振成像评估急性缺血性卒中缺血半暗带的研究进展
罗斓 欧阳烽 刘洁 曾献军

本文引用格式 罗斓, 欧阳烽, 刘洁, 等. 多参数磁共振成像评估急性缺血性卒中缺血半暗带的研究进展[J]. 磁共振成像, 2026, 17(11): 138-144. DOI:10.12015/issn.1674-8034.2026.11.017.


[摘要] 缺血半暗带是急性缺血性卒中再灌注治疗的核心靶区,但其并非单一MRI序列可直接显示的固定解剖区域,而是随缺血时间、灌注下降程度、侧支代偿与代谢储备动态演变的组织状态。MRI主要通过不同替代指标对其进行间接表征:扩散加权成像(diffusion-weighted imaging, DWI)-液体衰减反转恢复(fluid-attenuated inversion recovery, FLAIR)错配用于发病时间不明者的溶栓筛选,动态磁敏感对比灌注成像与动脉自旋标记用于界定低灌注风险组织,氧摄取分数、酰胺质子转移加权成像及钠-23磁共振成像(sodium-23 magnetic resonance imaging, 23Na MRI)从氧代谢、酸化和离子稳态等角度提供探索性组织状态信息,体素内不相干运动及高级扩散成像则用于刻画梗死核心内部的异质性。各技术反映的病理生理环节不同,固定阈值与二元错配难以充分刻画组织状态动态演变。当前研究仍存在参数阈值与后处理流程不统一、新兴技术外部验证不足等局限,未来需加强标准化、多中心验证及多参数整合。本文从临床应用及病理生理层面梳理不同MRI替代指标,综述半暗带多参数MRI评估的技术原理与研究进展,并探讨多参数整合与人工智能在组织结局预测中的前景,为急性缺血性卒中的组织状态评估、再灌注治疗影像筛选及相关研究提供参考。
[Abstract] The ischemic penumbra is the principal tissue target of reperfusion therapy in acute ischemic stroke. However, it is not a fixed anatomical region directly visualized by any single MRI sequence. Rather, it represents a dynamic tissue state shaped by ischemic duration, the severity of perfusion impairment, collateral compensation, and metabolic reserve. MRI assesses the penumbra indirectly through multiple surrogate markers. Diffusion-weighted imaging-fluid-attenuated inversion recovery (DWI-FLAIR) mismatch can support intravenous thrombolysis selection in patients with an unknown time of onset. Dynamic susceptibility contrast perfusion-weighted imaging and arterial spin labeling help identify hypoperfused tissue at risk. MRI-based oxygen extraction fraction measurements, amide proton transfer-weighted imaging, and sodium-23 magnetic resonance imaging (23Na MRI) provide exploratory information on oxygen metabolism, tissue acidosis, and ionic homeostasis, respectively. Intravoxel incoherent motion and advanced diffusion imaging seek to characterize heterogeneity within the ischemic core. Because these techniques reflect distinct aspects of ischemic pathophysiology, fixed thresholds and binary mismatch criteria cannot fully capture dynamic changes in tissue state. Current evidence is limited by inconsistent parameter thresholds and post-processing workflows and insufficient external validation of emerging techniques; future studies should emphasize standardization, multicenter validation, and multiparametric integration. This review integrates the clinical applications and pathophysiological basis of MRI surrogate markers, summarizes the technical principles and recent advances in multiparametric MRI assessment of the ischemic penumbra, and discusses the potential of multiparametric integration and artificial intelligence for tissue outcome prediction, with the aim of informing tissue-state assessment, imaging-based selection for reperfusion therapy, and related research in acute ischemic stroke.
[关键词] 急性缺血性卒中;缺血半暗带;磁共振成像;灌注成像;氧摄取分数;人工智能
[Keywords] acute ischemic stroke;ischemic penumbra;magnetic resonance imaging;perfusion imaging;oxygen extraction fraction;artificial intelligence

罗斓    欧阳烽    刘洁    曾献军 *  

南昌大学第一附属医院影像科,南昌 330006

通信作者:曾献军,E-mail: xianjun-zeng@126.com

作者贡献声明:曾献军拟定本综述的写作思路,对稿件重要内容进行修改,获得了国家自然科学基金项目的资助;罗斓设计、起草和撰写稿件,获取、分析和解释本综述的参考文献;欧阳烽、刘洁获取、分析和解释本综述的参考文献,对稿件重要内容进行了修改;全体作者都同意发表最后的修改稿,同意对本研究的所有方面负责,确保本研究的准确性和诚信。


基金项目: 国家自然科学基金项目 82360341
收稿日期:2026-08-26
接受日期:2026-10-15
中图分类号:R445.2  R743.3 
文献标识码:A
DOI: 10.12015/issn.1674-8034.2026.11.017
本文引用格式 罗斓, 欧阳烽, 刘洁, 等. 多参数磁共振成像评估急性缺血性卒中缺血半暗带的研究进展[J]. 磁共振成像, 2026, 17(11): 138-144. DOI:10.12015/issn.1674-8034.2026.11.017.

0 引言

       卒中是全球主要的死亡和长期致残原因之一,随着人口老龄化其负担持续增加。急性缺血性卒中(acute ischemic stroke, AIS)的治疗获益,取决于能否在不可逆损伤形成前恢复缺血组织血流。Astrup和Symon等提出的半暗带理论指出,脑血流量(cerebral blood flow, CBF)下降后神经元电活动停止早于细胞膜功能衰竭,而介于两者之间的组织虽已丧失功能,但及时再灌注后仍可存活[1],即缺血半暗带。缺血半暗带并非核心周围恒定存在的解剖区域,而是随缺血时间、血流下降程度、闭塞部位及侧支循环不断变化的动态状态[2]。

       早期AIS治疗主要依据发病时间筛选患者,相关指南与研究逐步确立并拓展了静脉溶栓及取栓的时间窗[3, 4, 5, 6, 7]。然而,发病时间相同、闭塞部位相似者,梗死增长速度可明显不同:良好的软脑膜侧支可延缓低灌注组织向不可逆梗死转化,侧支代偿不足则常伴核心快速扩张[8, 9]。治疗决策因而由统一的“时间窗”转向影像支持的“组织窗”——DAWN和DEFUSE 3依据症状-核心不匹配或灌注-核心错配,将部分大血管闭塞(large vessel occlusion, LVO)患者的取栓窗延长至16~24 h;WAKE-UP和EXTEND则分别证实,扩散加权成像(diffusion-weighted imaging, DWI)-液体衰减反转恢复(fluid-attenuated inversion recovery, FLAIR)错配与灌注成像可筛选发病时间不明或超时间窗仍能获益的溶栓患者[10, 11, 12, 13]。

       但治疗筛选所用的影像替代指标并不等同于半暗带本身,如DWI-FLAIR错配主要反映病灶时间,灌注错配主要反映血流动力学异常等,而半暗带本质上是代谢和组织命运的概念。据此,本文将相关MRI指标区分为三个层次:(1)病理生理概念,即缺血半暗带;(2)MRI替代指标,即反映病灶时间、血流动力学、氧代谢、酸化、离子稳态或微结构损伤的影像参数;(3)临床治疗筛选工具,即经临床试验验证并用于溶栓或取栓患者选择的影像标准,如DWI-FLAIR错配和特定灌注错配标准。三者相互关联,但不能等同。既往综述多聚焦半暗带影像技术演变或特定成像方法,对不同MRI指标的病理生理定位、证据成熟度及其与治疗筛选标准的关系缺乏统一梳理[14, 15],本文采用“病理生理概念—MRI替代指标—临床治疗筛选工具”的三层定位框架,比较不同MRI技术的临床定位和局限,并讨论多参数整合与组织命运预测,为AIS影像评估和再灌注治疗决策提供参考。

1 文献检索方法

       为全面梳理缺血半暗带多参数MRI评估的研究进展,本文检索PubMed、Web of Science Core Collection、中国知网和万方数据库。检索时间范围为建库至2026年8月。英文检索式主要围绕缺血半暗带、急性缺血性卒中及MRI相关技术构建,检索式如下:("ischemic penumbra" OR "penumbral imaging" OR "tissue window")AND("acute ischemic stroke" OR "ischemic stroke")AND("magnetic resonance imaging" OR MRI OR "diffusion-weighted imaging" OR DWI OR "perfusion-weighted imaging" OR PWI OR Tmax OR "arterial spin labeling" OR ASL OR "susceptibility-weighted imaging" OR SWI OR "oxygen extraction fraction" OR OEF OR "amide proton transfer" OR "sodium MRI" OR "23Na MRI" OR "intravoxel incoherent motion" OR IVIM)。中文检索式:(“缺血半暗带” OR “组织窗” OR “可挽救组织”)AND(“急性缺血性卒中” OR “缺血性卒中” OR “脑梗死”)AND(“磁共振成像” OR “扩散加权成像” OR “灌注加权成像” OR “Tmax” OR “动脉自旋标记” OR “磁敏感加权成像” OR “氧摄取分数” OR “酰胺质子转移” OR “钠磁共振” OR “体素内不相干运动”)。同时追溯相关综述、指南、关键临床试验及方法学研究的参考文献。纳入标准:(1)研究内容与急性缺血性卒中缺血半暗带的病理生理、MRI评估、治疗筛选或组织命运预测直接相关;(2)能够提供MRI技术原理、临床应用、验证结果或方法学依据的原创研究、随机对照试验、队列研究、指南、共识、系统综述或Meta分析。排除标准:重复发表、无法获取全文或关键信息不完整。最终结合主题相关性及参考文献追溯,纳入并引用85篇文献进行综合评述。

2 半暗带的病理生理基础与MRI评估

2.1 从二分模型到缺血损伤连续谱

       传统模型将缺血区分为不可逆梗死核心、半暗带和良性寡血区,为理解再灌注获益提供了清晰框架。近年研究则强调,三者并非边界清楚的分隔区域,而更接近由灌注不足、代谢代偿、膜功能障碍和细胞死亡构成的连续谱[16, 17]。即使影像上同属梗死核心或低灌注区,不同患者脑组织的代谢能力与恢复潜力也不同。其生理学基础在于,血流下降初期脑组织通过提高氧摄取分数(oxygen extraction fraction, OEF)维持脑氧代谢率(cerebral metabolic rate of oxygen, CMRO2)。灌注继续下降时OEF接近代偿上限,CMRO2降低,神经元电活动受抑。持续缺血最终引起三磷酸腺苷(adenosine triphosphate, ATP)耗竭、Na⁺/K⁺-ATP酶功能障碍与细胞毒性水肿[18, 19],随后炎症、内皮损伤及血脑屏障(blood-brain barrier, BBB)通透性增加进一步加重水肿[20]。综上,半暗带的形成与维持不仅取决于血流是否降低,更取决于组织能否通过氧摄取与代谢调节维持膜功能,单一影像参数难以精确刻画半暗带。

2.2 MRI指标的评估层面与临床定位

       临床常用的三类“错配”分别对应缺血级联的不同环节:灌注加权成像(perfusion-weighted imaging, PWI)与DWI错配表示灌注异常范围大于扩散受限范围,提示部分低灌注组织尚未出现细胞毒性水肿[21];磁敏感加权成像(susceptibility-weighted imaging, SWI)静脉征象与DWI范围不匹配,从脱氧血红蛋白增加的角度提示氧摄取代偿[22];DWI-FLAIR错配则利用扩散受限早于T2/FLAIR高信号的时间差,辅助判断病灶时间[23]。三类指标分别反映血流、氧代谢和时间演变,互为补充,不能相互替代。

       明确各指标所对应的病理环节和适用范围,比寻找单一MRI半暗带替代参数更为重要。灌注延迟区可包含良性寡血组织,DWI异常及表观扩散系数(apparent diffusion coefficient, ADC)降低也不等同于不可逆梗死,部分病灶在及时再灌注后可出现信号逆转或体积缩小[24]。因此,半暗带评估通常需要结合不同MRI序列提供的互补信息(表1)。

表1  缺血半暗带相关MRI替代指标的评估维度、临床定位及局限
Tab. 1  Assessment dimensions, clinical positioning, and limitations of MRI surrogate markers related to the ischemic penumbra

3 临床治疗筛选相关MRI评估

       目前具有较成熟临床证据的MRI筛选策略主要包括基于病灶时间的DWI-FLAIR错配及基于动态磁敏感对比灌注加权成像(dynamic susceptibility contrast perfusion-weighted imaging, DSC-PWI)的灌注-扩散错配。

3.1 DWI-FLAIR错配

       缺血发生后,脑组织ATP快速耗竭,Na⁺/K⁺-ATP酶功能受损,离子泵功能障碍导致细胞毒性水肿和水分子扩散受限,表现为DWI高信号和ADC降低[25, 26, 27];相比之下,FLAIR对早期细胞毒性水肿相对不敏感,其高信号通常随组织含水量进一步增加、T2弛豫时间延长及缺血性组织损伤进展而逐渐出现,故部分早期AIS病灶可呈DWI阳性、FLAIR阴性的错配模式。PRE-FLAIR及WAKE-UP研究证实,该错配可提高对发病4.5 h内或时间不明患者的识别率,并用于MRI指导的溶栓选择[12, 23]。但DWI-FLAIR错配主要提供病灶时间信息,并不代表全部DWI异常组织均可恢复;FLAIR高信号也不必然排除可挽救组织。

       当前,联合DWI与FLAIR特征的深度学习模型可辅助识别发病4.5 h内卒中[28, 29],而基于DWI预测错配或生成合成FLAIR的方法则可能进一步简化扫描流程[30]。FLAIR评估正由人工二分类逐步转向基于高信号体积、信号强度比等指标的连续量化与自动化识别,以保留更多分级信息[31]。然而,这些模型训练标签多源于人工判读或已知发病时间,可能存在误差;现有研究的病灶类型较为局限,且对小病灶、后循环病变及LVO患者的适用性仍需多中心外部验证[31, 32]。

3.2 DSC-PWI与灌注-扩散错配

       DSC-PWI利用钆对比剂首过的T2*信号变化,经动脉输入函数(arterial input function,AIF)反卷积获得CBF、脑血容量、平均通过时间和达峰时间(time to maximum, Tmax)[33],与DWI联合即可比较低灌注与扩散异常的范围;DEFUSE 2等研究表明,预设的灌注-扩散错配与血管内再灌注后的临床反应有关,为延长时间窗试验奠定了影像学基础[34]。

       Tmax延长综合反映大血管闭塞、侧支供血迟缓、灌注压下降及微循环灌注障碍,并非直接的组织存活指标。临床研究常以Tmax>6 s界定低灌注组织。该阈值主要来源于DEFUSE研究对不同Tmax延迟阈值与组织结局关系的分析[35],并在DEFUSE 2及EPITHET-DEFUSE联合分析中进一步应用[34, 36],因此属于经验性操作阈值,而非直接经组织病理学验证的生理阈值[37]。其测量受AIF选择、反卷积及延迟校正算法、采集参数和后处理软件影响。后循环核心与半暗带阈值可能不同于前循环[38]。近期DISTAL研究的12个月随访显示,中等及远端血管闭塞(medium/distal vessel occlusion, MeVO/DMVO)患者的血管内治疗未显示总体功能结局获益[39],提示此类患者的影像筛选仍需进一步研究。

4 补充性灌注与侧支评估

       低灌注强度比(hypoperfusion intensity ratio, HIR)为重度灌注延迟体积占Tmax>6 s低灌注体积的比例,可间接反映侧支代偿,MeVO/DMVO人群中较高HIR与更大的随访梗死体积相关[40],LVO患者中较低HIR与溶栓后早期再通概率增加相关[41]。定量侧支映射还显示,脑小血管病负担未必削弱软脑膜侧支供血[42]。

4.1 FLAIR血管高信号:侧支与慢血流

       FLAIR血管高信号(FLAIR vascular hyperintensity, FVH)表现为FLAIR图像上脑沟或皮质表面的异常高信号血管影。近端动脉闭塞后,软脑膜侧支可经迂回路径逆行供应闭塞远端组织,其血流较正常顺行血流迟缓;缓慢血流可使正常流空效应减弱,从而形成FVH[43, 44, 45];因此,远端FVH可提示缓慢的侧支血流,但也可见于缓慢顺行血流或血流淤滞,不能简单等同于良好侧支。近期研究提示,FVH-DWI错配可能与近端大脑中动脉(middle cerebral artery, MCA)闭塞患者的灌注半暗带及晚时间窗再血管化获益相关[46, 47, 48]。FVH-Alberta卒中项目早期CT评分(Alberta Stroke Program Early CT Score, ASPECTS)也与发病时间不明患者的结局相关[49]。现有证据主要来自观察性研究和前循环近端MCA闭塞患者,且受闭塞部位、扫描参数及判读方法影响,因此FVH宜作为侧支与慢血流的补充征象,而非独立的半暗带或治疗筛选标准[43, 45, 46]。

4.2 动脉自旋标记:无对比剂灌注评估

       动脉自旋标记(arterial spin labeling, ASL)以动脉血水质子为内源性示踪剂,由标记与对照图像的差值估计CBF[50]。伪连续ASL(pseudo-continuous ASL, pCASL)兼顾标记效率与硬件可实现性,已成为临床常用方案[51]。ASL无需对比剂且可重复采集,适用于肾功能受损或需连续监测者。

       其主要限制是信噪比较低并对动脉到达时间高度敏感:严重狭窄或侧支路径延长时,单一标记后延迟(post-labeling delay, PLD)时间可能低估真实灌注,血管内高信号又可能同时包含延迟到达与侧支信息[52]。系统评价显示,pCASL与其他灌注技术有一定一致性,但研究间方案、参考标准和阈值差异明显,尚不足以建立独立的半暗带判定标准[53];多反转时间ASL可动态观察血流到达过程,其侧支分级与数字减影血管造影一致性较好,提示多时间点采集有助于减少单一延迟的偏差[54]。在结局评价方面,基线或治疗后ASL-CBF与最终梗死体积及临床结局相关,多PLD时间灌注ASPECTS可进一步提高预测能力[55, 56]。而再灌注后高灌注则具有双重意义,既可能反映半暗带的有效挽救,也可能与BBB损伤和出血性转化风险有关[57]。

5 代谢与组织命运评估

5.1 OEF、CMRO2与SWI

       OEF和CMRO2评价组织对氧的摄取与消耗,更能接近半暗带的代谢定义。SWI“刷征”反映缺血区深髓静脉脱氧血红蛋白增加,与更严重的半暗带氧代谢障碍相关,但属间接征象,受静脉解剖与序列参数影响[58]。定量研究显示,基线OEF异常可预测成功再灌注后的梗死增长[59],入院OEF映射还可能预测取栓后DWI病灶的恢复,提示扩散受限组织中仍可含可逆成分[60];软脑膜侧支可缓冲供氧下降,故OEF并非仅由局部灌注决定[61];成功再灌注后,梗死组织的相对OEF自24~72 h至3个月、12个月逐渐升高,说明代谢状态具有时间依赖性,单次急性期测量难以概括组织的长期演变[62]。不过,定量磁化率成像、相位法与定量血氧水平依赖成像在信号来源和模型假设上各有差异,尚缺乏统一阈值与多中心验证。

5.2 酰胺质子转移加权成像与钠-23磁共振成像

       如果说OEF评估的是氧的供需平衡,酰胺质子转移加权成像(amide proton transfer-weighted imaging,APTw)与钠-23磁共振成像(sodium-23 magnetic resonance imaging, 23Na MRI)分别从组织酸化和离子稳态角度反映能量衰竭后的组织改变。APTw属于化学交换饱和转移成像,利用酰胺质子与水质子间的交换效应成像[63]。缺血后无氧糖酵解增强、乳酸积聚和pH降低会影响质子交换速率,故APTw可从组织酸化角度补充扩散和灌注成像,其参数与卒中严重程度及预后有关[64]。其价值在于对灌注异常区进一步分层:明显酸化可能提示已接近代谢失代偿,未明显酸化者或具有更好的代偿储备[65]。但APTw信号不等同于绝对pH测量,还受移动蛋白浓度、T1弛豫、磁化转移及B0/B1不均匀影响,其增量价值仍需与DWI-PWI及OEF直接比较。

       23Na MRI则从离子稳态角度观察缺血损伤:能量衰竭后细胞内钠增加,最终坏死区的钠信号在急性和亚急性期上升更快,23Na MRI与DWI可分别反映离子性水肿与细胞毒性水肿,但受敏感度低、分辨率有限及扫描时间长的限制,仍以研究应用为主[66]。故23Na信号变化反映离子稳态破坏及损伤进程,但尚不能据此直接判定组织损伤不可逆。

5.3 体素内不相干运动及高级扩散成像

       高级扩散成像可进一步揭示梗死核心及其周围组织的微循环和微结构异质性。体素内不相干运动(intravoxel incoherent motion, IVIM)成像基于多b值DWI,将信号衰减分解为真实扩散与微血管血流引起的伪扩散,获得D、D*和灌注分数f,理论上无需对比剂即可同时提供扩散与微循环信息[67]。临床研究显示,IVIM参数在梗死核心、灌注异常区与对侧正常脑组织间存在差异,并可能与长期结局相关[68]。临床前模型中,IVIM估算的局部CBF与经局部AIF校正的DSC-CBF一致性较好,可用于构建灌注-扩散错配[69]。但各研究在b值设置、拟合算法和区域定义上异质性较大,D*和f的稳定性尤为有限,IVIM尚不能形成成熟的半暗带阈值[70]。

       其他扩散衍生指标,如扩散衍生血管密度(diffusion-derived vessel density, DDVD)以少量b值估计微血管相关信号,初步显示出描绘半暗带的可能[71];扩散峰度成像界定的异常核心可小于传统DWI,提示部分DWI异常区在微结构层面尚未达到同等程度,高级扩散参数与功能结局预测间亦显示初步关联[72, 73]。这些方法多来自单中心或小样本研究,其研究价值最终取决于能否在标准DWI之外增加组织结局预测信息。

6 临床定位与多参数整合

6.1 MRI与计算机断层成像:临床场景中的互补定位

       计算机断层成像(computed tomography, CT)及CT血管成像(computed tomography angiography, CTA)检查快速、急诊可及性高,易于建立标准化卒中流程;CT灌注成像(computed tomography perfusion, CTP)可进一步评估灌注状态[74]。MRI的DWI对早期缺血敏感,结合FLAIR、PWI/ASL及其他高级序列,可提供组织时相、灌注及部分微结构信息,且无电离辐射。然而,MRI受检查时间、设备可及性、监护条件及患者配合度限制。因此,两类技术应根据临床场景互补应用,而非简单替代。由于成像原理、后处理算法及参数定义不同,CTP与MR-PWI的灌注阈值亦不能未经验证直接互换[75]。

6.2 多参数整合与人工智能

6.2.1 多参数整合的病理生理基础

       半暗带由时间、灌注、代谢、侧支及微循环共同决定,多参数整合的目的并非简单叠加序列,而是将不同病理环节的信息转换为可解释的组织结局概率。无监督多模态MRI影像组学可在不预设传统核心和半暗带标签的情况下识别不同缺血表型,为发现组织异质性提供新的分析方式[76]。深度生成模型还可由常规DWI和FLAIR合成MRI灌注参数图,并已完成外部验证,提示常规序列中可能包含可用于推断灌注状态的隐含信息[77]。

6.2.2 人工智能模型的优势与局限

       然而,人工智能(artificial intelligence, AI)模型性能的上限受到训练标签质量限制。若模型以Tmax阈值或随访梗死作为“真值”,就可能同时学习到原有阈值误差、再灌注治疗影响和随访时点差异。模型在单一中心取得较高性能,也不代表其能够跨磁场强度、厂商和后处理平台稳定迁移。因此,AI研究除报告受试者层面的准确率外,还应明确数据划分、外部验证、校准性能和临床决策增益。

6.2.3 跨平台一致性与标准化

       此外,半暗带灌注成像评估的固定阈值便于快速决策,却可能忽略低灌注程度、位置和持续时间的差异。多参数 AI灌注模型整合多个灌注图与临床信息,在重度低灌注组织估计上优于单一Tmax阈值[78];低灌注体积与信号强度并非同步变化,时间、强度和体积联合评价可更完整地描述灌注动态变化[79];不同自动化软件的核心和半暗带体积估计仍存在差异,提示跨平台一致性与后处理标准化是临床推广的前提[80]。

6.2.4 再灌注后评估与组织命运

       半暗带评估不止于术前。血管成功再通并不总能带来组织层面的完全再灌注,取栓后早期MRI仍可见与残余远端栓子或微循环障碍有关的低灌注[81],即使造影显示完全再灌注,24 h灌注影像仍可能发现异常[82],这有助于解释成功再通后梗死继续增长的原因。

       组织命运还受到BBB完整性和微循环再灌注的影响。灌注MRI估计的治疗前BBB渗漏与随访梗死形成有关,提示血管壁损伤可能帮助区分同等低灌注程度下的不同风险组织[83]。侧支循环决定缺血组织能够维持多久,也影响血管再通能否转化为组织再灌注和临床获益。试验及转化研究显示,软脑膜侧支可调节再灌注过程并减少徒劳性再通[84]。另一方面,成功取栓后仍可能发生无复流,即大血管已经再通但微循环灌注未能充分恢复[85]。因此,未来组织命运模型应联合考虑大血管再通、侧支供血、残余低灌注、BBB通透性及代谢状态,以解释无效灌注的临床现象。

7 小结与展望

       任何单一MRI参数均难以完整描述缺血半暗带的范围和可逆性。DWI-FLAIR错配主要提供病灶时间信息,DSC-PWI和ASL用于评价灌注异常,OEF、CMRO₂、APTw及23Na MRI从不同角度反映代谢储备和损伤程度,IVIM与高级弥散成像则尝试揭示核心内部的微循环和微结构异质性。现阶段,临床决策仍应以经过验证的扩散和灌注指标为基础,新兴代谢及微结构成像技术应作为补充而非替代。未来,多参数整合和AI有望推动半暗带评价由固定阈值和二元错配转向连续、个体化的组织命运预测,但其可重复性、跨平台迁移能力及临床增量价值仍需高质量前瞻性研究验证。

[1]
ASTRUP J, SIESJÖ B K, SYMON L. Thresholds in cerebral ischemia-the ischemic penumbra[J]. Stroke, 1981, 12(6): 723-725. DOI: 10.1161/01.STR.12.6.723.
[2]
PENSATO U, DEMCHUK A M, MENON B K, et al. Cerebral Infarct Growth: Pathophysiology, Pragmatic Assessment, and Clinical Implications[J]. Stroke, 2025, 56(1): 219-229. DOI: 10.1161/STROKEAHA.124.049013.
[3]
HACKE W, KASTE M, BLUHMKI E, et al. Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke[J]. N Engl J Med, 2008, 359(13): 1317-1329. DOI: 10.1056/NEJMoa0804656.
[4]
SHARMA R, LEE K. Advances in treatments for acute ischemic stroke[J/OL]. BMJ, 2025, 389: e076161 [2026-08-26]. https://doi.org/10.1136/bmj-2023-076161. DOI: 10.1136/bmj-2023-076161.
[5]
GOYAL M, MENON B K, VAN ZWAM W H, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials[J]. Lancet, 2016, 387(10029): 1723-1731. DOI: 10.1016/S0140-6736(16)00163-X.
[6]
PRABHAKARAN S, GONZALEZ N R, ZACHRISON K S, et al. 2026 Guideline for the Early Management of Patients With Acute Ischemic Stroke: A Guideline From the American Heart Association/American Stroke Association[J/OL]. Stroke, 2026, 57(8): e316-e436 [2026-08-26]. https://doi.org/10.1161/STR.0000000000000513. DOI: 10.1161/STR.0000000000000513.
[7]
SAVER J L. Time Is Brain—Quantified[J]. Stroke, 2006, 37(1): 263-266. DOI: 10.1161/01.STR.0000196957.55928.ab.
[8]
MAGUIDA G, SHUAIB A. Collateral Circulation in Ischemic Stroke: An Updated Review[J]. J Stroke, 2023, 25(2): 179-198. DOI: 10.5853/jos.2022.02936.
[9]
MANGIARDI M, PEZZELLA F R, ALFANO G. From "time is brain" to "time is collaterals": updates on the role of cerebral collateral circulation in stroke[J]. J Thromb Thrombolysis, 2025, 58(7): 821-832. DOI: 10.1007/s11239-025-03135-w.
[10]
NOGUEIRA R G, JADHAV A P, HAUSSEN D C, et al. Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct[J]. N Engl J Med, 2018, 378(1): 11-21. DOI: 10.1056/NEJMoa1706442.
[11]
ALBERS G W, MARKS M P, KEMP S, et al. Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging[J]. N Engl J Med, 2018, 378(8): 708-718. DOI: 10.1056/NEJMoa1713973.
[12]
THOMALLA G, SIMONSEN C Z, BOUTITIE F, et al. MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset[J]. N Engl J Med, 2018, 379(7): 611-622. DOI: 10.1056/NEJMoa1804355.
[13]
MA H, CAMPBELL B C V, PARSONS M W, et al. Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke[J]. N Engl J Med, 2019, 380(19): 1795-1803. DOI: 10.1056/NEJMoa1813046.
[14]
VASIREDDI A, SCHAEFER P W, ROHATGI S. Metabolic imaging of acute ischemic stroke (PET, 1Hydrogen spectroscopy, 17Oxygen imaging, 23Sodium MRI, pH imaging)[J]. Neuroimaging Clin N Am, 2024, 34(2): 271-280. DOI: 10.1016/j.nic.2024.01.002.
[15]
CHALET L, BOUTELIER T, CHRISTEN T, et al. Clinical imaging of the penumbra in ischemic stroke: from the concept to the era of mechanical thrombectomy[J/OL]. Front Cardiovasc Med, 2022, 9: 861913 [2026-08-26]. https://doi.org/10.3389/fcvm.2022.861913. DOI: 10.3389/fcvm.2022.861913.
[16]
PENSATO U, OSPEL J M, GANESH A, et al. Redefining the Cerebral Ischemic Core-Penumbra-Oligemia Continuum[J]. Stroke, 2026, 57(7): 2237-2247. DOI: 10.1161/STROKEAHA.126.055331.
[17]
BARON J C. The core/penumbra model: implications for acute stroke treatment and patient selection in 2021[J]. Eur J Neurol, 2021, 28(8): 2794-2803. DOI: 10.1111/ene.14916.
[18]
JIANG D, LU H. Cerebral oxygen extraction fraction MRI: Techniques and applications[J]. Magn Reson Med, 2022, 88(2): 575-600. DOI: 10.1002/mrm.29272.
[19]
HOSSMANN K A. Viability thresholds and the penumbra of focal ischemia[J]. Ann Neurol, 1994, 36(4): 557-565. DOI: 10.1002/ana.410360404.
[20]
YANG Y, ROSENBERG G A. Blood–Brain Barrier Breakdown in Acute and Chronic Cerebrovascular Disease[J]. Stroke, 2011, 42(11): 3323-3328. DOI: 10.1161/STROKEAHA.110.608257.
[21]
SCHLAUG G, BENFIELD A, BAIRD A E, et al. The ischemic penumbra: operationally defined by diffusion and perfusion MRI[J]. Neurology, 1999, 53(7): 1528-1537. DOI: 10.1212/WNL.53.7.1528.
[22]
DARWISH E A F, ABDELHAMEED-EL-NOUBY M, GENEIDY E. Mapping the ischemic penumbra and predicting stroke progression in acute ischemic stroke: the overlooked role of susceptibility weighted imaging[J/OL]. Insights Imaging, 2020, 11(1): 6 [2026-08-26]. https://doi.org/10.1186/s13244-019-0810-y. DOI: 10.1186/s13244-019-0810-y.
[23]
THOMALLA G, CHENG B, EBINGER M, et al. DWI-FLAIR mismatch for the identification of patients with acute ischaemic stroke within 4·5 h of symptom onset (PRE-FLAIR): a multicentre observational study[J]. Lancet Neurol, 2011, 10(11): 978-986. DOI: 10.1016/S1474-4422(11)70192-2.
[24]
NAGARAJA N, FORDER J R, WARACH S, et al. Reversible diffusion-weighted imaging lesions in acute ischemic stroke: a systematic review[J]. Neurology, 2020, 94(13): 571-587. DOI: 10.1212/WNL.0000000000009173.
[25]
HLADKY S B, BARRAND M A. Alterations in brain fluid physiology during the early stages of development of ischaemic oedema[J/OL]. Fluids Barriers CNS, 2024, 21(1): 51 [2026-08-26]. https://doi.org/10.1186/s12987-024-00534-8. DOI: 10.1186/s12987-024-00534-8.
[26]
ČIVRNÝ J, TOMÁŠ D, ČERNÁ M. MRI of cerebral oedema in ischaemic stroke and its current use in routine clinical practice[J]. Neuroradiology, 2024, 66(3): 305-315. DOI: 10.1007/s00234-023-03262-2.
[27]
MOSELEY M E, COHEN Y, MINTOROVITCH J, et al. Early detection of regional cerebral ischemia in cats: Comparison of diffusion- and T2-weighted MRI and spectroscopy[J]. Magn Reson Med, 1990, 14(2): 330-346. DOI: 10.1002/mrm.1910140218.
[28]
LI J, LIN Z, XIN Y, et al. StrokeDiffNet: quantifying DWI-FLAIR mismatch via a common feature space for time since stroke classification[J]. Med Biol Eng Comput, 2026, 64(7): 2503-2520. DOI: 10.1007/s11517-026-03598-w.
[29]
NAMGUNG E, KIM Y S, LEE E J, et al. Deep learning to identify stroke within 4.5 h using DWI and FLAIR in a prospective multicenter study[J/OL]. Sci Rep, 2025, 15(1): 26262 [2026-08-26]. https://doi.org/10.1038/s41598-025-10804-6. DOI: 10.1038/s41598-025-10804-6.
[30]
BENZAKOUN J, SCHELDEMAN L, WOUTERS A, et al. Automated DWI-FLAIR mismatch assessment in stroke using DWI only[J/OL]. Eur Stroke J, 2026, 11(1): 23969873251362712 [2026-08-26]. https://doi.org/10.1093/esj/23969873251362712. DOI: 10.1093/esj/23969873251362712.
[31]
OFFERSEN C J M, JOHANSEN J, SHENG K, et al. Quantification Beyond Binary of MR FLAIR Hyperintensity Lesions in Acute Ischemic Stroke of Unknown Time Since Onset[J/OL]. Diagnostics (Basel), 2026, 16(11): 1641 [2026-08-26]. https://doi.org/10.3390/diagnostics16111641. DOI: 10.3390/diagnostics16111641.
[32]
SORBY-ADAMS A, GUO J, DE HAVENON A, et al. Diffusion-Weighted Imaging Fluid-Attenuated Inversion Recovery Mismatch on Portable, Low-Field Magnetic Resonance Imaging Among Acute Stroke Patients[J]. Ann Neurol, 2024, 96(2): 321-331. DOI: 10.1002/ana.26954.
[33]
ØSTERGAARD L, WEISSKOFF R M, CHESLER D A, et al. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis[J]. Magn Reson Med, 1996, 36(5): 715-725. DOI: 10.1002/mrm.1910360510.
[34]
LANSBERG M G, STRAKA M, KEMP S, et al. MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study[J]. Lancet Neurol, 2012, 11(10): 860-867. DOI: 10.1016/S1474-4422(12)70203-X.
[35]
OLIVOT J M, MLYNASH M, THIJS V N, et al. Optimal Tmax Threshold for Predicting Penumbral Tissue in Acute Stroke[J]. Stroke, 2009, 40(2): 469-475. DOI: 10.1161/STROKEAHA.108.526954.
[36]
OGATA T, CHRISTENSEN S, NAGAKANE Y, et al. The effects of alteplase 3 to 6 hours after stroke in the EPITHET-DEFUSE combined dataset: post hoc case-control study[J]. Stroke, 2013, 44(1): 87-93. DOI: 10.1161/STROKEAHA.112.668301.
[37]
CALAMANTE F, CHRISTENSEN S, DESMOND P M, et al. The Physiological Significance of the Time-to-Maximum (Tmax) Parameter in Perfusion MRI[J]. Stroke, 2010, 41(6): 1169-1174. DOI: 10.1161/STROKEAHA.110.580670.
[38]
EDWARDS L S, CAPPELEN-SMITH C, CORDATO D, et al. Optimal CT perfusion thresholds for core and penumbra in acute posterior circulation infarction[J/OL]. Front Neurol, 2023, 14: 1092505 [2026-08-26]. https://doi.org/10.3389/fneur.2023.1092505. DOI: 10.3389/fneur.2023.1092505.
[39]
FISCHER U, BREHM A, RIBO M, et al. Endovascular treatment for medium or distal vessel occlusion stroke (DISTAL): 12-month outcomes of a multicentre, open-label, randomised trial[J]. Lancet Neurol, 2026, 25(6): 571-580. DOI: 10.1016/S1474-4422(26)00169-9.
[40]
YEDAVALLI V, SALIM H A, LAKHANI D, et al. Hypoperfusion intensity ratio is associated with follow-up infarct volume in medium vessel occlusions: A multicenter multinational study[J/OL]. Neurotherapeutics, 2025, 22(6): e00713 [2026-08-26]. https://doi.org/10.1016/j.neurot.2025.e00713. DOI: 10.1016/j.neurot.2025.e00713.
[41]
SENERS P, TURC G, LION S, et al. Relationships between brain perfusion and early recanalization after intravenous thrombolysis for acute stroke with large vessel occlusion[J]. J Cereb Blood Flow Metab, 2020, 40(3): 667-677. DOI: 10.1177/0271678X19836288.
[42]
POLKOWSKI C, HELWIG N, SEKER F, et al. Cerebral small vessel disease does not impair leptomeningeal collateral supply in large-vessel occlusion-Results from quantitative collateral mapping with MRI[J]. J Cereb Blood Flow Metab, 2026, 46(1): 66-77. DOI: 10.1177/0271678X251358972.
[43]
LEE K Y, KIM J W, PARK M, et al. Interpretation of fluid-attenuated inversion recovery vascular hyperintensity in stroke[J]. J Neuroradiol, 2022, 49(3): 258-266. DOI: 10.1016/j.neurad.2021.01.009.
[44]
SANOSSIAN N, SAVER J L, ALGER J R, et al. Angiography reveals that fluid-attenuated inversion recovery vascular hyperintensities are due to slow flow, not thrombus[J]. AJNR Am J Neuroradiol, 2009, 30(3): 564-568. DOI: 10.3174/ajnr.A1388.
[45]
PÉREZ DE LA OSSA N, HERNÁNDEZ-PÉREZ M, DOMÈNECH S, et al. Hyperintensity of distal vessels on FLAIR is associated with slow progression of the infarction in acute ischemic stroke[J]. Cerebrovasc Dis, 2012, 34(5-6): 376-384. DOI: 10.1159/000343658.
[46]
LUO L, ZHOU G, MENG F, et al. Comparison between MRI FLAIR vascular hyperintensity-DWI mismatch and perfusion based triage for thrombectomy in the late time window[J/OL]. Front Neurol, 2024, 15: 1400524 [2026-08-26]. https://doi.org/10.3389/fneur.2024.1400524. DOI: 10.3389/fneur.2024.1400524.
[47]
BOULLET M, MARNAT G, BOYER A, et al. FLAIR Vascular Hyperintensities/DWI Mismatch Predicts Penumbra in Proximal Middle Cerebral Artery Occlusion[J]. Stroke, 2026, 57(4): 982-991. DOI: 10.1161/STROKEAHA.125.053277.
[48]
LEGRAND L, TURC G, EDJLALI M, et al. Benefit from revascularization after thrombectomy according to FLAIR vascular hyperintensities-DWI mismatch[J]. Eur Radiol, 2019, 29(10): 5567-5576. DOI: 10.1007/s00330-019-06094-y.
[49]
INOUE M, KAMOGAWA N, KOGA M, et al. Associations between fluid-attenuated inversion recovery vessel hyperintensities and Alberta stroke program early CT score and clinical outcomes in stroke patients with unknown time of onset: A sub-analysis from a randomized controlled trial[J]. Int J Stroke, 2026, 21(3): 409-418. DOI: 10.1177/17474930251377522.
[50]
WILLIAMS D S, DETRE J A, LEIGH J S, et al. Magnetic resonance imaging of perfusion using spin inversion of arterial water[J]. Proc Natl Acad Sci U S A, 1992, 89(1): 212-216. DOI: 10.1073/pnas.89.1.212.
[51]
ALSOP D C, DETRE J A, GOLAY X, et al. Recommended implementation of arterial spin-labeled perfusion MRI for clinical applications: A consensus of the ISMRM perfusion study group and the European consortium for ASL in dementia[J]. Magn Reson Med, 2015, 73(1): 102-116. DOI: 10.1002/mrm.25197.
[52]
IUTAKA T, DE FREITAS M B, OMAR S S, et al. Arterial Spin Labeling: Techniques, Clinical Applications, and Interpretation[J/OL]. Radiographics, 2023, 43(1): e220088 [2026-08-26]. https://doi.org/10.1148/rg.220088. DOI: 10.1148/rg.220088.
[53]
KROTH J B, GUARDA S N F, WANG D J J, et al. Reliability of Pseudocontinuous Arterial Spin-Labeling in Ischemic Stroke and Comparison with Other Perfusion Techniques: Systematic Review and Meta-Analysis[J]. AJNR Am J Neuroradiol, 2026, 47(4): 929-936. DOI: 10.3174/ajnr.A9031.
[54]
KONG C, FENG Q, YANG T, et al. Dynamically grading cerebral collateral circulation using 3D multi-inversion time arterial spin labeling in ischemic stroke: a comparison with digital subtraction angiography[J/OL]. Front Neurol, 2025, 16: 1553216 [2026-08-26]. https://doi.org/10.3389/fneur.2025.1553216. DOI: 10.3389/fneur.2025.1553216.
[55]
HERNANDEZ PETZSCHE M R, BÜRKLE J, HOFFMANN G, et al. Cerebral blood flow from arterial spin labeling as an imaging biomarker of outcome after endovascular therapy for ischemic stroke[J]. J Cereb Blood Flow Metab, 2025, 45(2): 219-232. DOI: 10.1177/0271678X241267066.
[56]
LI Q, JIANG C, QIAN L, et al. Prognostic value of multi-PLD ASL-based cerebral perfusion ASPECTS in acute ischemic stroke[J/OL]. Front Neurol, 2024, 15: 1476937 [2026-08-26]. https://doi.org/10.3389/fneur.2024.1476937. DOI: 10.3389/fneur.2024.1476937.
[57]
JIN Y, BAI X, GUO D, et al. The prognostic impact of arterial spin labeling hyperperfusion in acute ischemic stroke: a systematic review and meta-analysis[J]. Acta Radiol, 2025, 66(2): 218-227. DOI: 10.1177/02841851241300328.
[58]
CRITON G, HERMIER M, DE BOURGUIGNON C, et al. The Brush Sign Is Associated with a More Severe Oxygen Metabolic Impairment of the Ischemic Penumbra: An MRI-Based Study in Patients with Acute Stroke[J]. AJNR Am J Neuroradiol, 2025, 46(8): 1557-1564. DOI: 10.3174/ajnr.A8723.
[59]
ASGHARIAHMADABAD M, ISMAIL A, METANAT P, et al. Oxygen Extraction Fraction on Baseline MRI Predicts Infarction Growth in Successfully Reperfused Patients[J]. Stroke, 2025, 56(10): 3024-3033. DOI: 10.1161/STROKEAHA.125.051270.
[60]
BANI-SADR A, HERMIER M, DE BOURGUIGNON C, et al. Oxygen Extraction Fraction Mapping on Admission Magnetic Resonance Imaging May Predict Recovery of Hyperacute Ischemic Brain Lesions After Successful Thrombectomy: A Retrospective Observational Study[J]. Stroke, 2024, 55(11): 2685-2693. DOI: 10.1161/STROKEAHA.124.047311.
[61]
BANI-SADR A, PATURAL P, RIVA R, et al. Influence of collateral circulation on cerebral oxygen metabolism assessed by MRI in acute ischemic stroke[J/OL]. J Neuroradiol, 2026, 53(5): 101577 [2026-08-26]. https://doi.org/10.1016/j.neurad.2026.101577. DOI: 10.1016/j.neurad.2026.101577.
[62]
KATAIKE V M, DESMOND P M, STEWARD C, et al. Oxygen extraction fraction changes in ischemic tissue from 24–72 hours to 12 months after successful reperfusion[J]. J Cereb Blood Flow Metab, 2025, 45(9): 1748-1759. DOI: 10.1177/0271678X251333940.
[63]
JABEHDAR MARALANI P, CHAN R W, LAM W W, et al. Chemical Exchange Saturation Transfer MRI: What Neuro-Oncology Clinicians Need To Know[J/OL]. Technol Cancer Res Treat, 2023, 22: 15330338231208613 [2026-08-26]. https://doi.org/10.1177/15330338231208613. DOI: 10.1177/15330338231208613.
[64]
ZHOU L, PAN W, HUANG R, et al. Amide Proton Transfer-Weighted MRI, Associations with Clinical Severity and Prognosis in Ischemic Strokes[J]. J Magn Reson Imaging, 2024, 60(6): 2509-2517. DOI: 10.1002/jmri.29333.
[65]
HEO H Y, TEE Y K, HARSTON G, et al. Amide proton transfer imaging in stroke[J/OL]. NMR Biomed, 2023, 36(6): e4734 [2026-08-26]. https://doi.org/10.1002/nbm.4734. DOI: 10.1002/nbm.4734.
[66]
COTINAT M, MESSAOUDI N, ROBINET E, et al. Dynamics of Ionic and Cytotoxic Edema During Acute and Subacute Stages of Patients With Ischemic Stroke: Complementarity of 23Na MRI and Diffusion MRI[J/OL]. NMR Biomed, 2025, 38(5): e70028 [2026-08-26]. https://doi.org/10.1002/nbm.70028. DOI: 10.1002/nbm.70028.
[67]
LE BIHAN D. What can we see with IVIM MRI?[J]. Neuroimage, 2019, 187: 56-67. DOI: 10.1016/j.neuroimage.2017.12.062.
[68]
ZIMMERMANN J, REOLON B, MICHELS L, et al. Intravoxel incoherent motion imaging in stroke infarct core and penumbra is related to long-term clinical outcome[J/OL]. Sci Rep, 2024, 14(1): 29631 [2026-08-26]. https://doi.org/10.1038/s41598-024-81280-7. DOI: 10.1038/s41598-024-81280-7.
[69]
LIU M M, SAADAT N, ROTH S P, et al. A Method for Imaging the Ischemic Penumbra with MRI Using Intravoxel Incoherent Motion[J]. AJNR Am J Neuroradiol, 2025, 46(7): 1336-1344. DOI: 10.3174/ajnr.A8656.
[70]
PIRES T, PRIYANKA, KADAVIGERE R, et al. Quantitative estimation of intravoxel incoherent motion parameters in acute ischemic stroke: A Systematic review and meta-analysis[J/OL]. BMC Med Imaging, 2025, 25(1): 462 [2026-08-26]. https://doi.org/10.1186/s12880-025-01997-3. DOI: 10.1186/s12880-025-01997-3.
[71]
CHEN J Q, LI C Y, WANG W, et al. Diffusion-derived vessel density (DDVD) for penumbra delineation in brain acute ischemic stroke: initial proof-of-concept results using single NEX DWI[J]. Quant Imaging Med Surg, 2024, 14(12): 9533-9542. DOI: 10.21037/qims-24-2139.
[72]
STEWARD C, VENKATRAMAN V, KATAIKE V M, et al. Diffusion Kurtosis Shows a Smaller Ischemic Core Versus Diffusion-Weighted MR in Early or Subacute Post-Thrombectomy Stroke[J/OL]. J Neuroimaging, 2025, 35(6): e70114 [2026-08-26]. https://doi.org/10.1111/jon.70114. DOI: 10.1111/jon.70114.
[73]
SAJUST DE BERGUES DE ESCALUP A, DURON L, SENERS P, et al. Prediction of functional outcome in patients with ischemic stroke using advanced diffusion-weighted MRI parameters at 3 Tesla[J]. Diagn Interv Imaging, 2026, 107(10): 335-342. DOI: 10.1016/j.diii.2026.03.001.
[74]
WINTERMARK M, SANELLI P C, ALBERS G W, et al. Imaging recommendations for acute stroke and transient ischemic attack patients: a joint statement by the American society of neuroradiology, the American college of radiology and the society of NeuroInterventional surgery[J]. J Am Coll Radiol, 2013, 10(11): 828-832. DOI: 10.1016/j.jacr.2013.06.019.
[75]
DANI K A, THOMAS R G R, CHAPPELL F M, et al. Computed tomography and magnetic resonance perfusion imaging in ischemic stroke: definitions and thresholds[J]. Ann Neurol, 2011, 70(3): 384-401. DOI: 10.1002/ana.22500.
[76]
RAMESH S, UMAPATHY S. Unsupervised discovery of ischemic stroke phenotypes from multimodal MRI radiomics[J/OL]. Biomed Phys Eng Express, 2025, 12(1): 015014 [2026-08-26]. https://doi.org/10.1088/2057-1976/ae2624. DOI: 10.1088/2057-1976/ae2624.
[77]
MATSULEVITS A, KOCH A, MAHÉ-VERDURE C, et al. Generating Synthetic MR Perfusion Maps From DWI and FLAIR in Acute Ischemic Stroke: Development and External Validation of a Deep Learning Model[J]. Stroke, 2026, 57(8): 2375-2387. DOI: 10.1161/STROKEAHA.126.055813.
[78]
BANI-SADR A, JUPIN-DELEVAUX E, FRINDEL C, et al. Multiparametric AI-based perfusion analysis outperforms Tmax thresholding for critically hypoperfused tissue estimation in acute ischemic stroke undergoing admission MRI[J/OL]. Eur J Radiol, 2026, 200: 112831 [2026-08-26]. https://doi.org/10.1016/j.ejrad.2026.112831. DOI: 10.1016/j.ejrad.2026.112831.
[79]
URBACH H, RAU A, BAGCILAR Ö, et al. Temporal Imaging Dynamics in Ischemic Stroke: Intensity- versus Volume-Based Metrics[J]. AJNR Am J Neuroradiol, 2026, 47(8): 2038-2045. DOI: 10.3174/ajnr.A9225.
[80]
KIM J, PARK J H, KIM D, et al. Comparative validation of automated perfusion analysis software for ischemic penumbra estimation and EVT decision-making[J/OL]. Front Neurosci, 2025, 19: 1660870 [2026-08-26]. https://doi.org/10.3389/fnins.2025.1660870. DOI: 10.3389/fnins.2025.1660870.
[81]
SCHIPHORST A TER, SENERS P, DARGAZANLI C, et al. Hypoperfusion on Early MRI Despite Successful Thrombectomy: A Prospective Imaging and Inflammatory Biomarkers Study[J]. Stroke, 2026, 57(3): 745-757. DOI: 10.1161/STROKEAHA.125.052873.
[82]
MUJANOVIC A, IMHOF A, ZHENG S, et al. Perfusion Abnormalities on 24-Hour Perfusion Imaging in Patients With Complete Endovascular Reperfusion[J]. Stroke, 2024, 55(9): 2315-2324. DOI: 10.1161/STROKEAHA.124.047441.
[83]
NÄGELE F L, SCHELDEMAN L, WOUTERS A, et al. Blood-Brain Barrier Leakage in the Penumbra Is Associated With Infarction on Follow-Up Imaging in Acute Ischemic Stroke[J]. Stroke, 2025, 56(7): 1832-1842. DOI: 10.1161/STROKEAHA.124.050171.
[84]
AMKI M EL, GLÜCK C, GLÜCK C, et al. Leptomeningeal collaterals regulate reperfusion in ischemic stroke and rescue the brain from futile recanalization[J/OL]. Neuron, 2024, 112(9): 1456-1472.e6 [2026-08-26]. https://doi.org/10.1016/j.neuron.2024.01.031. DOI: 10.1016/j.neuron.2024.01.031.
[85]
HORIE N, INOUE M, MORIMOTO T, et al. Recanalization Does Not Always Equate to Reperfusion: No-Reflow Phenomenon After Successful Thrombectomy[J]. Stroke, 2025, 56(1): 183-189. DOI: 10.1161/STROKEAHA.124.048994.

上一篇 代谢减重手术后肥胖症患者关键脑网络重构的MRI研究进展
下一篇 MRI定量脑白质高信号正常参考值及其在脑小血管病中的研究进展
  
诚聘英才 | 广告合作 | 免责声明 | 版权声明
联系电话:010-67113815
京ICP备19028836号-2